Welcome to the IAM Patent 1000 2016 – The World’s Leading Patent Professionals, the fifth edition of Intellectual Asset Management’s market-leading guide that identifies and profiles leading private practice patent professionals and firms in the world’s key jurisdictions.Read more
The IAM Patent 1000 is unique in being a one-stop resource that focuses exclusively on naming best-in-class patent prosecution, licensing and litigation practitioners on a global basis, as well as expert witnesses in the United States. For five months, a dedicated research team working out of our offices in London and Hong Kong conducted detailed interviews with thousands of private practice lawyers and attorneys based in dozens of countries, as well as the users of their services, in order to identify the practitioners and practices that are considered to excel at providing patent-related legal services. In the United States, we also asked interviewees to name the expert witnesses they turn to when they need world-class input on both damages and technical issues. The firms and individuals listed on the following pages are the results of that research.
All those listed in the IAM Patent 1000 are included because we received substantial positive feedback about them from multiple sources. We do not claim that we have managed to find every top name in every jurisdiction covered; but we are confident that we have included the vast majority, and that everybody who is listed fully deserves the recognition. For a detailed methodology that explains the research process, as well as how the research team decides who should finally be listed, please click here.
In addition to the listings and editorial, there is further biographical information on some of the individuals featured at the end of each country section, and on some of the selected firms at the end of each regional chapter. All those selected for inclusion in the IAM Patent 1000 are offered the opportunity to publish this information for a fee – some opt to do so, while others do not. Either way, it has no effect on listing or ranking decisions. The research was conducted entirely independently of any commercial considerations.
Search IAM Patent 1000
Tsar & Tsai Law Firm is a top-tier commercial law firm in Taiwan. The firm has more than 80 professional fee earners specialising in various legal fields. The firm has a long history of international practice and is known for its superior-quality work. It has maintained a diverse international character and prides itself on providing creative problem solving and strategic advice to clients. The firm has been broadly recognised in publications – including Chambers Asia, Chambers Global, the Legal 500, IFLR, Asia Legal Business, Asialaw Profiles and China Law Profiles – as one of the best in Taiwan. Tsar & Tsai is a full-service law firm and has decades of experience ...
Rothwell, Figg, Ernst & Manbeck, PC
For over 25 years, Steven Lieberman has specialised in patent litigation. Mr Lieberman has handled a variety of lawsuits in the pharmaceutical, electronics and computer software fields, both in the district courts (and on appeal) and before the International Trade Commission. In the pharmaceutical field, he has handled more than 30 such matters, including serving as lead counsel in In re Buspirone, in which Bristol Myers paid $535 million to settle the antitrust counterclaims brought by Mr Lieberman’s client and others. Mr Lieberman has also acted as lead counsel for parties in a wide variety of patent cases outside the pharmaceutical area, representing clients such as The ...
The Australian IP market has been a hotbed of activity over the past year. The public listings of Spruson & Ferguson and Shelston IP turned heads, while patent prosecutors have been responding to commercial pressure to expand overseas. Fisher Adams Kelly’s merger with Callinans and its subsequent acquisition by IPH exemplify the ongoing consolidation of filing operations. On the wider front, only time will tell how the continued squeeze on prices will influence the legal market as a whole. Case highlights of 2015 included the reversal of the Federal Court decision in Myriad Genetics; the High Court ultimately ruled that isolated nucleic acids are not patentable subject ...
Register for more free content
- Read more IAM blogs and articles
- Receive the editor's weekly review by email